Iain Stuart
2022
In 2022, Iain Stuart earned a total compensation of $653.9K as Chief Scientific Officer at VYNE Therapeutics, a 49% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $143,415 |
|---|---|
| Option Awards | $30,750 |
| Salary | $421,811 |
| Stock Awards | $45,750 |
| Other | $12,200 |
| Total | $653,926 |
Stuart received $421.8K in salary, accounting for 65% of the total pay in 2022.
Stuart also received $143.4K in non-equity incentive plan, $30.8K in option awards, $45.8K in stock awards and $12.2K in other compensation.
Rankings
In 2022, Iain Stuart's compensation ranked 3,814th out of 5,501 executives tracked by ExecPay. In other words, Stuart earned more than 30.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,814 out of 5,501 | 31st |
Division Manufacturing | 2,144 out of 2,980 | 28th |
Major group Chemicals And Allied Products | 1,027 out of 1,335 | 23rd |
Industry group Drugs | 961 out of 1,238 | 22nd |
Industry Pharmaceutical Preparations | 699 out of 892 | 22nd |
Source: SEC filing on November 13, 2023.
Stuart's colleagues
We found two more compensation records of executives who worked with Iain Stuart at VYNE Therapeutics in 2022.